NDC 33342-276

Darifenacin

Darifenacin

Darifenacin is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Macleods Pharmaceuticals Limited. The primary component is Darifenacin Hydrobromide.

Product ID33342-276_4b4427c3-48f9-4db3-9174-4cac6ae1e0ac
NDC33342-276
Product TypeHuman Prescription Drug
Proprietary NameDarifenacin
Generic NameDarifenacin
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2017-07-29
Marketing CategoryANDA / ANDA
Application NumberANDA207302
Labeler NameMacleods Pharmaceuticals Limited
Substance NameDARIFENACIN HYDROBROMIDE
Active Ingredient Strength8 mg/1
Pharm ClassesCholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 33342-276-07

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-276-07)
Marketing Start Date2017-07-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 33342-276-10 [33342027610]

Darifenacin TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA207302
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-07-29

NDC 33342-276-07 [33342027607]

Darifenacin TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA207302
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-07-29

NDC 33342-276-12 [33342027612]

Darifenacin TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA207302
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-07-29

Drug Details

Active Ingredients

IngredientStrength
DARIFENACIN HYDROBROMIDE7.5 mg/1

OpenFDA Data

SPL SET ID:7ae60119-e22c-4806-a5d8-db7c9e8984a2
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 485423
  • 485421
    • UPC Code
  • 0333342277107
  • 0333342276070
  • 0333342276100
  • 0333342277077

    • Pharmacological Class

    • Cholinergic Muscarinic Antagonist [EPC]
    • Cholinergic Muscarinic Antagonists [MoA]

    Medicade Reported Pricing

    33342027610 DARIFENACIN ER 7.5 MG TABLET

    Pricing Unit: EA | Drug Type:

    33342027607 DARIFENACIN ER 7.5 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Darifenacin" or generic name "Darifenacin"

    NDCBrand NameGeneric Name
    0591-4375Darifenacindarifenacin
    0591-4380Darifenacindarifenacin
    13668-202DarifenacinDarifenacin
    13668-203DarifenacinDarifenacin
    16571-767DarifenacinDarifenacin
    16571-768DarifenacinDarifenacin
    33342-276DarifenacinDarifenacin
    33342-277DarifenacinDarifenacin
    46708-223DARIFENACINDARIFENACIN
    46708-224DARIFENACINDARIFENACIN
    52605-067DarifenacinDarifenacin Hydrobromide
    52605-068DarifenacinDarifenacin Hydrobromide
    59746-516darifenacindarifenacin hydrobromide
    59746-517darifenacindarifenacin hydrobromide
    62332-223DARIFENACINDARIFENACIN
    69097-432DarifenacinDarifenacin
    69097-431DarifenacinDarifenacin
    62332-224DARIFENACINDARIFENACIN
    65862-862DarifenacinDarifenacin
    65862-861DarifenacinDarifenacin
    0430-0170Enablexdarifenacin
    0430-0171Enablexdarifenacin
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.